Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication – Name Confusion

Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication – Name Confusion

FDA is warning health care professionals and patients that reports of confusion between the antidepressant Brintellix and anti-blood clotting medication Brilinta have resulted in the wrong medication being prescribed or dispensed. FDA determined that the main reason for the confusion between these two medications is the similarity of their brand (proprietary) names. None of the reports indicates that a patient ingested the wrong medication; however, reports of prescribing and dispensing errors continue. [7/30/15]

Search